Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China
· Delayed Price · Currency is CNY 7.51
+0.20 (2.74%)
Apr 30, 2026, 1:00 PM CST
SHE:002349 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 6,065 | 6,023 | 6,228 | 7,222 | 9,835 | 9,184 | Upgrade
|
| Market Cap Growth | -0.01% | -3.29% | -13.75% | -26.57% | 7.09% | 130.20% | Upgrade
|
| Enterprise Value | 5,175 | 5,226 | 5,271 | 6,314 | 9,350 | 8,968 | Upgrade
|
| Last Close Price | 7.31 | 7.26 | 7.57 | 8.67 | 11.71 | 10.89 | Upgrade
|
| PE Ratio | 27.30 | 27.47 | 29.29 | 29.16 | 46.34 | 57.15 | Upgrade
|
| Forward PE | - | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | Upgrade
|
| PS Ratio | 4.15 | 4.13 | 4.44 | 4.78 | 6.25 | 6.76 | Upgrade
|
| PB Ratio | 1.93 | 1.91 | 2.11 | 2.58 | 3.75 | 3.57 | Upgrade
|
| P/TBV Ratio | 2.40 | 2.38 | 2.65 | 3.26 | 4.54 | 4.72 | Upgrade
|
| P/FCF Ratio | 18.92 | 18.79 | 22.24 | 27.47 | 33.14 | 40.81 | Upgrade
|
| P/OCF Ratio | 17.79 | 17.67 | 20.03 | 24.79 | 27.44 | 30.06 | Upgrade
|
| EV/Sales Ratio | 3.54 | 3.58 | 3.76 | 4.18 | 5.94 | 6.60 | Upgrade
|
| EV/EBITDA Ratio | 14.12 | 14.38 | 17.12 | 16.49 | 29.27 | 34.78 | Upgrade
|
| EV/EBIT Ratio | 18.20 | 18.41 | 22.62 | 21.14 | 44.24 | 57.30 | Upgrade
|
| EV/FCF Ratio | 16.14 | 16.30 | 18.82 | 24.01 | 31.50 | 39.85 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.04 | 0.06 | 0.07 | 0.75 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | 0.04 | 0.09 | 0.08 | 0.87 | Upgrade
|
| Net Debt / Equity Ratio | -0.41 | -0.41 | -0.37 | -0.43 | -0.39 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.54 | -3.54 | -3.60 | -3.18 | -3.24 | -2.60 | Upgrade
|
| Net Debt / FCF Ratio | -4.01 | -4.01 | -3.95 | -4.63 | -3.49 | -2.98 | Upgrade
|
| Asset Turnover | 0.43 | 0.43 | 0.43 | 0.49 | 0.50 | 0.43 | Upgrade
|
| Inventory Turnover | 2.57 | 2.57 | 2.57 | 2.61 | 2.69 | 2.34 | Upgrade
|
| Quick Ratio | 4.33 | 4.33 | 4.72 | 4.50 | 3.55 | 2.05 | Upgrade
|
| Current Ratio | 5.14 | 5.14 | 5.67 | 5.49 | 4.38 | 2.64 | Upgrade
|
| Return on Equity (ROE) | 8.58% | 8.58% | 8.59% | 10.19% | 8.18% | 5.54% | Upgrade
|
| Return on Assets (ROA) | 5.16% | 5.16% | 4.49% | 6.00% | 4.23% | 3.08% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.98% | 13.19% | 11.44% | 15.78% | 10.28% | 6.30% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.90% | 8.90% | 7.80% | 10.60% | 8.00% | 6.00% | Upgrade
|
| Earnings Yield | 3.62% | 3.64% | 3.41% | 3.43% | 2.16% | 1.75% | Upgrade
|
| FCF Yield | 5.29% | 5.32% | 4.50% | 3.64% | 3.02% | 2.45% | Upgrade
|
| Dividend Yield | 1.07% | - | 1.04% | 1.06% | 0.68% | 0.55% | Upgrade
|
| Payout Ratio | 38.76% | 38.76% | 35.52% | 26.64% | 25.44% | 27.69% | Upgrade
|
| Buyback Yield / Dilution | -0.58% | -0.58% | 0.01% | -0.02% | 0.00% | 0.03% | Upgrade
|
| Total Shareholder Return | 0.49% | -0.58% | 1.05% | 1.04% | 0.69% | 0.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.